Bhatt, D. L., Steg, P. G., Brinton, E. A., Jacobson, T. A., Miller, M., Tardif, J., . . . Ballantyne, C. M. (2017). Rationale and design of REDUCE‐IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial. Clinical cardiology (Mahwah, N.J.), 40(3), 138-148. https://doi.org/10.1002/clc.22692
Citace podle Chicago (17th ed.)Bhatt, Deepak L., et al. "Rationale and Design of REDUCE‐IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial." Clinical Cardiology (Mahwah, N.J.) 40, no. 3 (2017): 138-148. https://doi.org/10.1002/clc.22692.
Citace podle MLA (9th ed.)Bhatt, Deepak L., et al. "Rationale and Design of REDUCE‐IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial." Clinical Cardiology (Mahwah, N.J.), vol. 40, no. 3, 2017, pp. 138-148, https://doi.org/10.1002/clc.22692.